Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Titel:
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Auteur:
Garassino, Marina Chiara Cho, Byoung-Chul Kim, Joo-Hang Mazières, Julien Vansteenkiste, Johan Lena, Hervé Corral Jaime, Jesus Gray, Jhanelle E Powderly, John Chouaid, Christos Bidoli, Paolo Wheatley-Price, Paul Park, Keunchil Soo, Ross A Huang, Yifan Wadsworth, Catherine Dennis, Phillip A Rizvi, Naiyer A